<DOC>
	<DOC>NCT00046332</DOC>
	<brief_summary>This study will evaluate the drop in viral load over 10 days of treatment with S-1360 versus placebo in HIV-infected patients who have not previously taken anti-HIV medications.</brief_summary>
	<brief_title>A Study Comparing 4 Doses Of GW810781 Versus Placebo In HIV-Infected Patients</brief_title>
	<detailed_description />
	<mesh_term>HIV Infections</mesh_term>
	<criteria>No prior HIV medications. HIV infection with viral load &gt;40050,000 copies/mL. CD4 cell count &gt;50 cells/mm. Patients requiring medications that cannot be interrupted for the duration of the study. Abnormal ECG or other chronic health conditions as noted on screening physical exam. Previous participation in an experimental drug trial(s) within 30 days of the screening visit for this study.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2013</verification_date>
	<keyword>Integrase inhibitors</keyword>
	<keyword>Monotherapy</keyword>
	<keyword>HIV-1 infection</keyword>
</DOC>